Thrombophilic risk factors and peripheral arterial disease severity
- 1 January 2010
- journal article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 104 (07) , 71-77
Abstract
Few data are available on thrombophilic risk factors and progression of atherosclerotic peripheral arterial disease (PAD). Thrombophilic alterations can be an aggravating factor when arterial stenoses are present. In a cross-sectional study, we evaluated the presence of the thrombophilic factors fibrinogen, homocysteine, factor (F)VIII, lupus anticoagulant (LAC), FII G20210A, and FV R506Q mutations in 181 patients with PAD at Fontaine’s stage II (claudication), in 110 patients with critical limb ischaemia (CLI), and in 210 controls. Fibrinogen was higher in patients with CLI vs. those with claudication and controls (427.9 ± 10.5 vs. 373.1 ± 5.2 vs. 348.9 ± 7.0 p=0.001, respectively). Homocysteine and FVIII were higher in patients with PAD than in controls, but were similar in patients with CLI and claudication. The prevalence of LAC increased in patients with CLI vs. those with claudication and controls (21.4% vs. 7.8% vs. 5.2% p<0.001, respectively). The prevalence of FII 20210A allele was higher in patients with CLI vs. those with claudication and controls. Using a logistic model, FII G20210A mutation (odds ratio [OR] 19.8, confidence interval [CI] 4.5–87.1, p=0.001), LAC (OR 2.7, CI1.1–6.5, p=0.032), and fibrinogen (OR 1.01, CI 1.00–1.01, p=0.001) were associated with CLI, whereas homocysteine, FVIII, and FV R506Q mutation were not. CLI risk increased according to the number of thrombophilic alterations. In conclusion, altered levels of some important thrombophilic risk factors are independently associated with PAD severity. These data suggest that the presence of two or more thrombophilic risk factors raise the likelihood of PAD being more severe, justifying the need for larger longitudinal studies.Keywords
This publication has 26 references indexed in Scilit:
- Biobanks and the search for predictive biomarkers of local and systemic outcome in atherosclerotic diseaseThrombosis and Haemostasis, 2009
- Thrombophilia and Venous Thromboembolism: Implications for TestingSeminars in Thrombosis and Hemostasis, 2007
- Inflammatory, haemostatic, and rheological markers for incident peripheral arterial disease: Edinburgh Artery StudyEuropean Heart Journal, 2007
- Risk Factors for Progression of Peripheral Arterial Disease in Large and Small VesselsCirculation, 2006
- Hemostatic Factors, Inflammatory Markers, and Progressive Peripheral AtherosclerosisAmerican Journal of Epidemiology, 2005
- Thrombophilic risk factors for symptomatic peripheral arterial diseaseJournal of Vascular Surgery, 2005
- Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines.2003
- Relation of levels of hemostatic factors and inflammatory markers to the ankle brachial indexThe American Journal of Cardiology, 2003
- Venous thromboembolism in young women. Role of thrombophilic mutations and oral contraceptive useEuropean Heart Journal, 2002
- Gerinnungsphysiologische Schnellmethode zur Bestimmung des FibrinogensActa Haematologica, 1957